Literature DB >> 15698571

Structure and phosphatidylinositol-(3,4)-bisphosphate binding of the C-terminal PH domain of human pleckstrin.

Christian Edlich1, Gunter Stier, Bernd Simon, Michael Sattler, Claudia Muhle-Goll.   

Abstract

Pleckstrin is the major target of protein kinase C (PKC) in blood platelets. Its phosphorylation triggers responses that ultimately lead to platelet activation and blood clot formation. Pleckstrin consists of three domains: a pleckstrin homology (PH) domain at both termini and a central DEP (Dishevelled, Egl-1, Pleckstrin) domain. Here, we report the solution nuclear magnetic resonance (NMR) structure of the C-terminal PH domain (C-PH) of human pleckstrin-1. We show that this PH domain binds phosphatidylinositol-3,4-bisphosphate (PtdIns(3,4)P2) with high specificity in protein lipid overlay assays. Using NMR titration experiments and mutational analysis, residues involved in binding to PtdIns(3,4)P2 are identified. The binding site is formed by a patch of basic residues from the beta1 and beta2 strands and the beta1-beta2 loop. Since PtdIns(3,4)P2 is an important signaling molecule in platelets, our data suggest a C-PH dependent regulation of pleckstrin function in response to PtdIns(3,4)P2.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15698571     DOI: 10.1016/j.str.2004.11.012

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  14 in total

1.  Effect of zinc binding on β-amyloid structure and dynamics: implications for Aβ aggregation.

Authors:  Nasrollah Rezaei-Ghaleh; Karin Giller; Stefan Becker; Markus Zweckstetter
Journal:  Biophys J       Date:  2011-09-07       Impact factor: 4.033

2.  Determination of structural requirements and probable regulatory effectors for membrane association of maize sucrose synthase 1.

Authors:  Shane C Hardin; Kateri A Duncan; Steven C Huber
Journal:  Plant Physiol       Date:  2006-05-12       Impact factor: 8.340

3.  Crystallization and preliminary diffraction analysis of truncated human pleckstrin.

Authors:  Sean Jackson; Seiji Sugiman-Marangos; Kelvin Cheung; Murray Junop
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2011-02-25

4.  PtdIns(4,5)P-restricted plasma membrane localization of FAN is involved in TNF-induced actin reorganization.

Authors:  Dirk Haubert; Nina Gharib; Francisco Rivero; Katja Wiegmann; Marianna Hösel; Martin Krönke; Hamid Kashkar
Journal:  EMBO J       Date:  2007-06-28       Impact factor: 11.598

5.  Fission yeast Opy1 is an endogenous PI(4,5)P2 sensor that binds to the phosphatidylinositol 4-phosphate 5-kinase Its3.

Authors:  Chloe E Snider; Alaina H Willet; HannahSofia T Brown; Jun-Song Chen; Joshua M Evers; Kathleen L Gould
Journal:  J Cell Sci       Date:  2020-12-03       Impact factor: 5.285

6.  The dual PH domain protein Opy1 functions as a sensor and modulator of PtdIns(4,5)P₂ synthesis.

Authors:  Yading Ling; Christopher J Stefan; Jason A Macgurn; Anjon Audhya; Scott D Emr
Journal:  EMBO J       Date:  2012-05-04       Impact factor: 11.598

7.  Loss of pleckstrin defines a novel pathway for PKC-mediated exocytosis.

Authors:  Lurong Lian; Yanfeng Wang; Matthew Flick; John Choi; Edward W Scott; Jay Degen; Mark A Lemmon; Charles S Abrams
Journal:  Blood       Date:  2009-02-03       Impact factor: 22.113

8.  Inositol pentakisphosphate isomers bind PH domains with varying specificity and inhibit phosphoinositide interactions.

Authors:  Sean G Jackson; Sarra Al-Saigh; Carsten Schultz; Murray S Junop
Journal:  BMC Struct Biol       Date:  2011-02-10

9.  Structural analysis of the carboxy terminal PH domain of pleckstrin bound to D-myo-inositol 1,2,3,5,6-pentakisphosphate.

Authors:  Sean G Jackson; Yi Zhang; Richard J Haslam; Murray S Junop
Journal:  BMC Struct Biol       Date:  2007-11-22

10.  Structural analyses of the Slm1-PH domain demonstrate ligand binding in the non-canonical site.

Authors:  Kanchan Anand; Kenji Maeda; Anne-Claude Gavin
Journal:  PLoS One       Date:  2012-05-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.